ASX:IMEHealth Care Equipment & ServicesHealth Care Technology

IMEXHS ORD

$0.370
+$0.000 (+0.00%)
Day Range
$0.365 - $0.370
52 Week Range
$0.220 - $0.450
Volume
0.00
Avg Volume (10D)
15.70K
Market Cap
$19.95M
Price Chart
Market Statistics
Open$0.370
Previous Close$0.370
Day High$0.370
Day Low$0.365
52 Week High$0.450
52 Week Low$0.220
Valuation
Market Cap19.95M
Shares Outstanding53.92M
Price to Book1.37
Trading Activity
Volume0.00
Value Traded0.00
Bid$0.300 × 10,000
Ask$0.375 × 70
Performance
1 Day0.00%
5 Day12.12%
13 Week54.17%
52 Week2.78%
YTD-1.33%
Technical Indicators
RSI (14)67.74
50-Day SMA$0.279
Latest News
IMEXHS wins $2m radiology contract with Colombia’s National Police
Technology

IMEXHS wins $2m radiology contract with Colombia’s National Police

A wholly-owned subsidiary of medical imaging company IMEXHS (ASX: IME) has secured a $2 million radiology contract with the National Police of Colombia. The win is reported to be IMEXHS’ largest contract to date. Subsidiary IMEXHS RIMAB will provide world-class radiology outsourcing services to approximately 48,000 patients at a new police hospital in Bogota using […]

1 min read
Imelda Cotton
Imelda Cotton
Diagnostic imaging: which stock will become the next Pro Medicus?
Hot Topics

Diagnostic imaging: which stock will become the next Pro Medicus?

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s because they are cheap and convenient. The underlying tech hasn’t really moved on since 1895, when […]

6 min read
Tim Boreham
Tim Boreham
IMEXHS secures global partnership deal with Canon Medical Systems
Technology

IMEXHS secures global partnership deal with Canon Medical Systems

Medical imaging company IMEXHS (ASX: IME) signed a global partnership agreement with Vital Images, for its advanced visualisation software Vitrea, ahead of its half-year results, set to be published later this month. Earlier this month, IMEXHS received final device classification for its Hiruko Essential software suite in the US, which means it is clear to begin […]

2 min read
George Tchetvertakov
George Tchetvertakov
ImExHS receives FDA exemption and plots course to commercialise US market
Biotechnology

ImExHS receives FDA exemption and plots course to commercialise US market

Medical imaging company ImExHS (ASX: IME) has received an operational boost with regards to its US operations after receiving final device classification for its Hiruko Essential software suite. The news means ImExHS now has the all-clear to commercialise its product in the US under the country’s Code of Federal Regulations (CFR). ImExHS says it will […]

2 min read
George Tchetvertakov
George Tchetvertakov